CAS: 863971-17-9
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | MC-VC-PAB-MMAF REF: IN-DA01KWO7CAS: 863971-17-9 | 98% | To inquire | Tue 03 Dec 24 |
 | MC-Val-Cit-PAB-MMAF REF: TM-T18326CAS: 863971-17-9 | 98% | 226.00 €~1,730.00 € | Tue 10 Dec 24 |
 | Mc-Val-Cit-PAB-mmaf REF: 3D-NJB97117CAS: 863971-17-9 | Min. 95% | To inquire | Tue 14 Jan 25 |
MC-Val-Cit-PAB-MMAF
CAS:863971-17-9
MC-Val-Cit-PAB-MMAF: ADC drug-linker with antitumor MMAF, cleaved by cathepsin.
Formula:
C68H103N11O16
Purity:
98%
Color and Shape:
Solid
Molecular weight:
1330.61
Ref: TM-T18326
| 1mg | 226.00 € | ||
| 5mg | 469.00 € | ||
| 10mg | 744.00 € | ||
| 25mg | 1,286.00 € | ||
| 50mg | 1,730.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Mc-Val-Cit-PAB-mmaf
CAS:863971-17-9
Mc-Val-Cit-PAB-mmaf is a monomethyl auristatin conjugate that has been designed to selectively target tumor cells. …
Formula:
C68H103N11O16
Purity:
Min. 95%
Molecular weight:
1,330.6 g/mol
Ref: 3D-NJB97117
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Tuesday 14 Jan 2025
